Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

Nonobstructive azoospermia (NOA) affects 5%–15% of men undergoing infertility evaluation, accounting for nearly 60% of ...

The study, “Association of Male Hypogonadism with Risk of Hospitalization from COVID-19,” was published online Sept. 2 in JAMA Network Open. Sandeep Dhindsa, M.D., a professor of medicine and the ...

LifeMD, Inc.’s LFMD Rex MD has launched TestoRx, a direct-to-consumer hormone therapy telehealth service. TestoRx provides an ...

It’s a gradual process characterised by a conglomeration of physical, sexual, and psychological symptoms, which can be attributed to testosterone deficiency that develops later in life, also known as ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment ...